Evidence map›Paper›PMID 22207734›Full record

ArticleBlood2012

miR-27b controls venous specification and tip cell fate.

Dauren Biyashev, Dorina Veliceasa, Jacek Topczewski, Jolanta M Topczewska, Igor Mizgirev, Elena Vinokour, Alagarsamy L Reddi, Jonathan D Licht, Sergei Y Revskoy, Olga V Volpert

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Role of miRNAs in vascular development.Non-coding RNA research · 2023
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. tRNA-derived fragments tRFMolecular therapy. Nucleic acids · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Alagebrium targets the miR-27b/TSP-1 signaling pathway to rescue NAmerican journal of translational research · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Dauren BiyashevUrology Department, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Dorina Veliceasa
Jacek Topczewski
Jolanta M Topczewska
Igor Mizgirev
Elena Vinokour
Alagarsamy L Reddi
Jonathan D Licht
Sergei Y Revskoy
Olga V Volpert
Northwestern University · USMemorial Medical Center · USInstitute of Oncology NN Petrov · RU

Funding

Regulation of angiogenic balance by thrombospondin-1.R01HL068033 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI VOLPERT, OLGA VALERY · 2001 to 2009
$2.6M
Basic Science Training Grant in UrologyT32DK062716 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KLUMPP, DAVID J · 2003 to 2020
$2.0M
Developmental Aspects of Sexual Dimorphism of Hepatic Tumors: Zebrafish ModelR21CA139311 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI REVSKOY, SERGEI · 2009 to 2010
$369k
NCI NIH HHS R21 CA139311NCI NIH HHS R21CA139311NHLBI NIH HHS R01 HL068033NIDDK NIH HHS T32 DK062716
6 · The paper itself

Abstract

We discovered that miR-27b controls 2 critical vascular functions: it turns the angiogenic switch on by promoting endothelial tip cell fate and sprouting and it promotes venous differentiation. We have identified its targets, a Notch ligand Delta-like ligand 4 (Dll4) and Sprouty homologue 2 (Spry2). miR-27b knockdown in zebrafish and mouse tissues severely impaired vessel sprouting and filopodia formation. Moreover, miR-27b was necessary for the formation of the first embryonic vein in fish and controlled the expression of arterial and venous markers in human endothelium, including Ephrin B2 (EphB2), EphB4, FMS-related tyrosine kinase 1 (Flt1), and Flt4. In zebrafish, Dll4 inhibition caused increased sprouting and longer intersegmental vessels and exacerbated tip cell migration. Blocking Spry2 caused premature vessel branching. In contrast, Spry2 overexpression eliminated the tip cell branching in the intersegmental vessels. Blockade of Dll4 and Spry2 disrupted arterial specification and augmented the expression of venous markers. Blocking either Spry2 or Dll4 rescued the miR-27b knockdown phenotype in zebrafish and in mouse vascular explants, pointing to essential roles of these targets downstream of miR-27b. Our study identifies critical role of miR-27b in the control of endothelial tip cell fate, branching, and venous specification and determines Spry2 and Dll4 as its essential targets.

Indexed as

Neovascularization, PhysiologicAdaptor Proteins, Signal TransducingAnimalsAortaArteriesBiomarkersBlotting, NorthernBlotting, WesternCarcinoma, Lewis LungCell DifferentiationCell MovementEmbryo, NonmammalianEndothelium, VascularGene Expression ProfilingIntracellular Signaling Peptides and ProteinsMembrane ProteinsAdaptor Proteins, Signal TransducingBiomarkersdelta proteinIntracellular Signaling Peptides and ProteinsMembrane ProteinsMicroRNAsMirn27 microRNA, mouseProtein Serine-Threonine KinasesRNA, MessengerRNA, Small InterferingSpry2 protein, mouse

Identifiers

PMID22207734
PMCPMC3311282
OpenAlexW2110788884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.